XOMA. Bull or Bear? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear?

XOMA 24.85

-7.7%

Feb 5 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Slugger who wrote (11373)	8/18/1999 1:59:00 PM
From: aknahow	Read Replies (3) of 17367

On trauma, even after the DSMB meets I am not sure how much we should expect to learn. We may learn that it is safe, (expect that to be the case) and we may learn that the trial has not been halted for lack of efficiency, (I also expect that will be the case). I do not see how, "We'll know next month if it's working." Other than if the trial is not halted we will know it is doing something positive. I post this so that I at least don;t operate on a incorrect overly optimistic expectation. I will be quite happy with whatever information about the DSMB review, that XOMA releases but I have no expectation that it will be anything more than an update of minimal content and consequence.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next